Abilify Maintena 400 mg lyophilized powder for injection Images
Generic Name: aripiprazole
This medication has been identified as Abilify Maintena 400 mg lyophilized powder for injection. It is supplied by Otsuka Pharmaceutical Co., Ltd.
Abilify Maintena is used in the treatment of Bipolar Disorder; Schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Abilify Maintena 400 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Abilify Maintena
- Generic Name
- aripiprazole
- Strength
- 400 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Atypical antipsychotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Otsuka Pharmaceutical Co., Ltd
- National Drug Code (NDC)
- 59148-0019
More about Abilify Maintena (aripiprazole)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (69)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: atypical antipsychotics
- Breastfeeding
Patient resources
Other brands
Aristada, Abilify Asimtufii, Abilify Discmelt, Aristada Initio
Professional resources
Other brands
Aristada, Abilify Asimtufii, Aristada Initio, Opipza
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.